Physician
Murphy, Christopher
Murphy, Christopher was paid $2.29M by Medicaid between Jan 2018 and Dec 2024, across 115 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 15% of everything it billed.
33Billing provider infoMURPHY, CHRISTOPHER
BELLEVILLE, IL 62220
BELLEVILLE, IL 62220
33aNPI1487764890assigned 08/30/2006
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$2.29M
24GClaims334,171
24DCodes billed115
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Illinois
Rank by total paid#32 of 398
Median peer was paid$66K
This provider vs. median35×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 46,961 | $287K | |
| 2019 | 57,710 | $326K | |
| 2020 | 52,617 | $333K | |
| 2021 | 54,465 | $503K | |
| 2022 | 47,101 | $333K | |
| 2023 | 44,509 | $297K | |
| 2024incomplete | 30,808 | $208K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 15% | 14,213 | 11,589 | $335K |
| 80053 | Comprehensive metabolic panel | 9.9% | 42,545 | 31,433 | $226K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 6.5% | 46,271 | 31,960 | $148K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 6.2% | 3,680 | 2,788 | $142K |
| 84443 | Thyroid stimulating hormone (TSH) | 5.7% | 15,049 | 12,666 | $131K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 5.2% | 7,520 | 7,093 | $119K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 3.9% | 2,086 | 1,469 | $89K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 3.1% | 12,720 | 11,054 | $71K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 3.1% | 2,603 | 2,415 | $70K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.3% | 2,387 | 2,186 | $53K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 2.1% | 921 | 791 | $48K |
| 84484 | 1.9% | 8,213 | 5,738 | $43K |
103 more codes
| 83880 | 1.8% | 4,015 | $42K | |
| 80061 | Lipid panel | 1.6% | 10,183 | $38K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.5% | 4,433 | $33K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.5% | 7,515 | $33K |
| 83735 | 1.4% | 8,389 | $32K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.4% | 1,416 | $32K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.4% | 1,411 | $32K |
| 87040 | 1.4% | 2,690 | $32K | |
| 0240U | 1.4% | 427 | $31K | |
| 87081 | 1.3% | 9,905 | $30K | |
| 87186 | 1.2% | 4,430 | $28K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.2% | 3,378 | $27K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.1% | 8,101 | $26K |
| 83690 | 1.1% | 6,827 | $25K | |
| 81001 | 1.1% | 14,870 | $24K | |
| 82962 | 1.0% | 12,385 | $24K | |
| 82607 | <1% | 3,397 | $20K | |
| 81025 | <1% | 9,334 | $19K | |
| 84439 | <1% | 4,030 | $18K | |
| 83970 | <1% | 985 | $17K | |
| 82746 | <1% | 2,664 | $15K | |
| 85379 | <1% | 3,684 | $15K | |
| 83605 | <1% | 2,560 | $14K | |
| 85610 | <1% | 5,516 | $12K | |
| 85027 | <1% | 3,495 | $12K | |
| 85060 | <1% | 1,171 | $11K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 742 | $11K |
| 88307 | <1% | 351 | $10K | |
| 83550 | <1% | 2,119 | $9K | |
| 82805 | <1% | 990 | $9K | |
| 85730 | <1% | 2,212 | $9K | |
| 83540 | <1% | 2,183 | $8K | |
| 82728 | <1% | 1,924 | $8K | |
| 84702 | <1% | 1,482 | $8K | |
| 87070 | <1% | 1,938 | $7K | |
| 88304 | <1% | 357 | $6K | |
| 80050 | General health panel | <1% | 352 | $6K |
| 80074 | <1% | 284 | $5K | |
| 84481 | <1% | 988 | $5K | |
| 82570 | <1% | 1,717 | $5K | |
| 82248 | <1% | 1,723 | $4K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 117 | $4K |
| 82043 | <1% | 1,956 | $4K | |
| 86901 | <1% | 1,479 | $4K | |
| 87807 | <1% | 649 | $3K | |
| 87205 | <1% | 1,721 | $3K | |
| 88312 | <1% | 245 | $3K | |
| 86850 | <1% | 1,056 | $3K | |
| 86900 | <1% | 1,486 | $3K | |
| 82553 | <1% | 530 | $3K | |
| 86140 | <1% | 1,120 | $3K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 36 | $3K |
| 80076 | <1% | 564 | $2K | |
| 80164 | <1% | 496 | $2K | |
| G0433 | Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening | <1% | 522 | $2K |
| 86592 | <1% | 952 | $2K | |
| 80069 | <1% | 396 | $2K | |
| 81003 | <1% | 1,237 | $1K | |
| 83050 | <1% | 837 | $1K | |
| 85652 | <1% | 871 | $1K | |
| 82150 | <1% | 352 | $1K | |
| 86803 | <1% | 142 | $1K | |
| 84703 | <1% | 247 | $892.60 | |
| 84153 | <1% | 129 | $851.40 | |
| 82550 | <1% | 254 | $829.31 | |
| 80081 | <1% | 25 | $681.01 | |
| 84100 | <1% | 215 | $586.64 | |
| 85018 | <1% | 326 | $420.17 | |
| 87210 | <1% | 183 | $399.81 | |
| 87522 | Neg quan hep c or qual rna | <1% | 14 | $386.80 |
| 84550 | <1% | 142 | $316.32 | |
| 84146 | <1% | 45 | $300.51 | |
| 85014 | <1% | 188 | $259.90 | |
| 86431 | <1% | 65 | $235.30 | |
| 86038 | <1% | 28 | $217.63 | |
| 84156 | <1% | 174 | $198.95 | |
| 83721 | <1% | 43 | $177.79 | |
| 82261 | <1% | 15 | $140.03 | |
| 80047 | <1% | 29 | $119.18 | |
| 88108 | <1% | 30 | $115.70 | |
| 82533 | <1% | 15 | $100.65 | |
| 84132 | <1% | 38 | $96.53 | |
| 83520 | <1% | 12 | $76.08 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 18 | $70.40 |
| 82947 | <1% | 15 | $59.29 | |
| 83935 | <1% | 25 | $58.25 | |
| 84480 | <1% | 12 | $57.36 | |
| 83498 | <1% | 12 | $53.16 | |
| 83020 | <1% | 12 | $51.72 | |
| 80178 | <1% | 15 | $48.45 | |
| 82776 | <1% | 15 | $42.60 | |
| 84436 | <1% | 12 | $39.85 | |
| 82760 | <1% | 15 | $39.55 | |
| 82016 | <1% | 15 | $38.18 | |
| 82128 | <1% | 15 | $38.18 | |
| 87077 | <1% | 136 | $35.00 | |
| 82950 | <1% | 15 | $34.95 | |
| 82565 | <1% | 14 | $32.62 | |
| 84030 | <1% | 12 | $31.56 | |
| 82436 | <1% | 13 | $30.29 | |
| 84300 | <1% | 13 | $27.56 | |
| 84133 | <1% | 13 | $27.30 | |
| 84520 | <1% | 12 | $21.45 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.